Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
This story is reported by The New England Journal of Medicine. Read what other outlets are saying below, then open the original report for full details.
This story is reported by The New England Journal of Medicine. Read what other outlets are saying below, then open the original report for full details.